Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05p -7.69% 0.60p 0.55p 0.65p 0.60p 0.60p 0.60p 2,465,111 08:00:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.7 -0.1 - 17.26

Sareum Share Discussion Threads

Showing 28601 to 28625 of 28625 messages
Chat Pages: 1145  1144  1143  1142  1141  1140  1139  1138  1137  1136  1135  1134  Older
DateSubjectAuthorDiscuss
14/12/2018
10:07
Could be a sell from last month or few yrs ago. You just never know. Price destruction
spacedust
13/12/2018
17:16
After the bell 2m buy ......
hickersp
03/12/2018
19:55
Thats about right Cerrito. Down on good news is normal course of action on aim
spacedust
03/12/2018
17:07
While of course the ties between SAR and Sierra have weakened after the August Sierra acquisition from Gilead, I did check to see how Sierra's share price had reacted to the recent Sierra clinical announcements and indeed news of GSK acquisition; the answer is it drifted down today to $1.61..just above the 52 week low of 1.48.
cerrito
30/11/2018
16:17
Oh look th3 MMs listened to my advice. Tick up and back to 0.7p all set to finish flat. This game is way tooooo easier peasier lemon is much more squeazier
spacedust
30/11/2018
14:37
It will finish flat. Tick up before 4pm back to 0.7p
spacedust
30/11/2018
14:28
Down on excellent news. Imagine any mishaps......ouch
spacedust
30/11/2018
13:13
Market is stupid..... We are at the mercy of the market.... We are at the mercy of stupid???
spacedust
30/11/2018
12:27
The market is stupid😜 IMHO!
nobbygnome
30/11/2018
12:23
Doesn't make a difference after amendment either
spacedust
30/11/2018
09:56
Market on the other hand don't seem to give a toss.
spacedust
30/11/2018
07:52
Very interesting announcement today. Immunotherapy is the way of the future so if Sierra can tap into that we could be on to a winner!
nobbygnome
29/11/2018
22:35
Yes saw that and Sierra saying the preclinical work on lung cancer provides another potential application for SRA 737/chk1
cerrito
29/11/2018
22:19
Sierra RNS Sierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
birdiemaker
26/11/2018
09:58
Nothing normal service resumed
spacedust
20/11/2018
14:45
Sp is dropping now. What's going on?
rascotrading
15/11/2018
10:52
Quite positive. Don't think market has awaken to this news. I expect buys to come in
spacedust
15/11/2018
10:17
srra update rns chk1
d1gger
13/11/2018
15:43
them on board in Harper#s day. I note Parker’s reference to QCA guidelines. Just got round to reading the 10-Q of Sierra published last Thursday. No real surprise that no reference to a SRA 737 milestone; note however they say that they have a milestone payment on the horizon to Gilead and another one for Carna(upon dosing of the first patient in the first Phase 1 clinical trial for SRA141) no mention of a SRA 737 milestone. Do not want to come over as paranoid but reading today#s SRA press release, I get the impression that SRA 737 is not the apple of their eye as it was earlier in the year
cerrito
10/11/2018
12:10
The latest MIT Technology Review: Vol 121 No.6 Nov/Dec 2018 - "The Precision Medicine Issue" makes fascinating reading for anyone with an interest in healthcare trends. Could well inform investing decisions too :)
multibagger
09/11/2018
10:03
Well few more billions of buys might move this towards 1p
spacedust
08/11/2018
22:31
Had a busy day so just got round to reading the SRRA Q3. Solid progress and understandable to me that the SAR share price was unchanged. I also see the SRRA price was unchanged at $1.67. Somewhat surprised that SRA 737-04 did not get a mention...should I have been? A bit spooked that they Sierra said (as I read it) with respect to the PARP trial-SRA 737-03- quote We are currently evaluating the optimal timing of these trials within the context of our recently expanded portfolio." unquote. Not clear to me what will trigger a milestone payment before SAR's cash runs out.
cerrito
08/11/2018
16:11
Rns out!!!
spacedust
31/10/2018
13:39
Large trades going through.
spacedust
30/10/2018
13:30
I doubt it on the news front. Might have to wait till next month for that.....
spacedust
Chat Pages: 1145  1144  1143  1142  1141  1140  1139  1138  1137  1136  1135  1134  Older
Your Recent History
LSE
SAR
Sareum
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181217 17:35:27